(2026). Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens. JAC-Antimicrobial Resistance.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Update on the Comparative in Vitro Activity of Cefiderocol and Four β-lactam–β-lactamase-inhibitor Combinations Against Clinically Important Gram-negative Pathogens."
JAC-Antimicrobial Resistance 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Update on the Comparative in Vitro Activity of Cefiderocol and Four β-lactam–β-lactamase-inhibitor Combinations Against Clinically Important Gram-negative Pathogens."
JAC-Antimicrobial Resistance, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.